Poonam Sharma, MBBS
Poonam Sharma, MBBS

Poonam Sharma, MBBS

Professor
Chair, SOM - Department of Pathology
Director, Medical Laboratory
School of Medicine

Expertise/Specializations

  • Anatomic and Surgical Pathology
  • Gastrointestinal Pathology

Academic Appointments

Department

  • Pathology

Position

  • Professor

Secondary Appointment

  • School of Pharmacy and Health Professions

Education

  • Membership of Royal College of Obstetricians & Gynecologists (MRCOG), Royal College of Obstetricians & Gynecologists, London, England (1998)
  • Anatomic and Clinical Pathology Residency Program, University of Nebraska Medical Center, Omaha, Nebraska (1999-2003)
  • Surgical pathology, Loyola University Medical Center, Chicago (2003-2004)
  • Lady Hardinge Medical College, University of Delhi, India (1991)

Certifications

American Board of Anatomic and Clinical Pathology (2004)

Publications and Presentations

Articles

  • Subramanian S1, Pallati PK2, Rai V1, Sharma P3, Agrawal DK1, Nandipati KC1,2.  Increased expression of triggering receptor expressed on myeloid cells-1 in the population with obesity and insulin resistance.. [Epub ahead of print], Obesity (Silver Spring), doi: 10.1002/oby.21714, 2017
  • RaiV, Sharma P, Agrawal S, Agrawal DK.  Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research.  , Molecular and Cellular Biochemistry, 424(1-2) doi: 10.1007/s11010-016-2849-0. , 123-145 PMID: 27766529, 2017
  • Foster JM1, Sleightholm RL2, Wahlmeier S2, Loggie B3, Sharma P2Patel A2. Early identification of DPAM in at-risk low-grade appendiceal mucinous neoplasm patients: a new approach to surveillance for peritoneal metastasis., World J Surg Oncology, 14(1) doi: 10.1186/s12957-016-0996-0, 243, 2016
  • Bates C, Gordon L, Travis E, Chatterjee A, Chaudron L, Fivush B, Gulati M, Jagsi R, Sharma P, Gillis M, Ganetzky R, Grover A, Lautenberger D, Moses AStriving for Gender Equity in Academic Medicine Careers:  A Call to Action, Academic Medicine, 91, 8, 2016
  • Book chapter reference ” Shetty S, Thomas P, Govindarajan V, Sharma P, Sirineri G, and Loggie B.W. Pseudomyxoma Peritonei as a special subset of peritoneal carcinomatosis. Future Medicine, Advances in the Management of Peritoneal Cancers:, Esquivel J. ed. Future Science Group., Not Applicable, Doi:10.2217/ebo.13.223, 124-135, 2014
  • Lohani K, Shetty S, Sharma P, Govindarajan V, Thomas P, Loggie B. Pseudomyxoma Peritonei: Inflammatory Responses in the Peritoneal Microenvironment.  Epub 2013 Sep 18., Annals of Surgical Oncology, 21(5) doi: 10.1245/s10434-013-3261-6, 1441-7, 2014
  • Shetty S, Natarajan B, Thomas P, Govindarajan V, Sharma P, Loggie B. Proposed Classification of Pseudomyxoma Peritonei: Influence of Signet Ring Cells on Survival., Am J Surg, 79(11) , 1171-6, 2013
  • Xie Y, Abel PW, Kirui JK, Deng C, Sharma P, Wolff DW, Toews ML, Tu Y. Identification of upregulated phosphoinositide 3-kinase γ as a target to suppress breast cancer cell migration and invasion., Biochem Pharmacol, 85(10), 1454-1462, 2013
  • Majhi PD, Lakshmanan I,  Ponnusamy MP, Jain M, Das S, Shimizu ST, Kaur S, West WW, Johansson S, Smith LM, Yu F, Rolle C, Sharma P, Carey G, Batra SK, Ganti AK. Pathobiological implications of MUC4 in non-small cell lung cancer., Journal of Thoracic Oncology, 8(4), 398-407, 2013
  • Sharma P, Montgomery E. Gastrointestinal Dysplasia., Pathology, 45(3), 273-285, 2013
  • Shetty S, Thomas P, Ramanan B, Sharma P, Govindarajan V, Loggie B. Kras mutations and p53 overexpression in pseudomyxoma peritonei: association with phenotype and prognosis., J Surg Res, 180(1), 97-103, 2013
  • Trowbridge R, Sharma P, Hunter WJ, Agrawal DK. Vitamin D receptor expression in the mucosal tissue at the gastroesophageal junction., Experimental and Molecular Pathology, 93(2), 246-249, 2012
  • Trowbridge R, Sharma P, Hunter WJ, Agrawal DK.  Vitamin D receptor expression and neoadjuvant therapy in esophageal adenocarcinoma., Experimental and Molecular Pathology, 93(1), 147-153, 2012
  • Chakraborty S, Sharma P, Roman J, Richards S. Where Suspicion Bore Fruit- An Unusual Cause of Abdominal Pain in a 46 Year Old Man., The Internet Journal of Surgery, 28, 5, 2012

Publications

  • Agrawal, D. K., Rai, V., Sharma, P., Agrawal, S. “Relevance of Mouse Models of Cardiac Fibrosis and Hypertrophy in Cardiac Research.  Molecular and Cellular Biochemistry, Molecular and Cellular Biochemistry, Manuscript MCBI-D-16-00972R1, 2016

Presentations

  • Grand Rounds by Dr. Sharma “Role of Pathologist in Value Based Care: From Behind the Microscope to the Forefront” (CUMC-OMA)
     , 2016
  • Poster Presentation -
    “Desmoplastic Small Round Cell Tumor of the Prostate: An Extremely Rare Entity (Poster No. 193), (on -line publication only http://www.archivesofpathology.org/toc/ arpa/ 140/9) John M. Gross, MD; Dan Anderson, MD; Poonam Sharma, MD. CAP Annual Meeting, Las Vegas, Nevada
     , 2016
  • Conducted a presentation at the National Society of Histologists meeting entitled “IHC Evaluation of ER & PR receptor Status in Breast Cancer”, approved by the National Society for Histotechnology Education Committee for 1.5 Contact hours (NSH # 22747), 2014
  • “IHC Evaluation of ER & PR receptor Status in Breast Cancer”, approved by the National Society for Histotechnology Education Committee for 1.5 Contact hours (NSH # 22747),, 2014
  • "Immunohistochemistry in the Evaluation of Breast Pathology". Objectives: Describe the role of immunohistochemical markers in evaluation of breast pathology. 2. Outline the strategies for selection and interpretation of IHC in commonly encountered scenarios. 3. Summarized the pitfalls in use of IHC in breast pathology., 2014
  • American College of Surgeons 2014 Clinical Congress, San Francisco, California, October 26-30, 2014, reference: Judge, S., Shetty, S., Thomas, P., Govindarajan, V., Sharma, P., Loggie, B., Factors associated with survival in patients with pseudomyxoma peritonei: influence of signet ring cells., 2014
  • “Microsatellite Instability Testing in Colorectal Cancer: What is the significance?”  22nd Annual Management of Colon & Rectal Diseases by Primary Care Physicians & Their Support Staff CME Conference, Omaha, Nebraska, 2014
  •  “Clinicopathologic Case Studies: Focus on Hereditary Non-Polyposis Colorectal Cancer and Familial Adenomatous Polyposis,” 23rd Annual Winter Meeting Midwest Society of Colon and Rectal Surgeons, Park City, Utah, 2014
  • “The Pathologist’s Role in Diagnosis and Management of Non-Small Cell Lung Cancer”, 2013
  • “Molecular Diagnostics of Colorectal Neoplasms,” 21th Annual Management of Colon & Rectal Diseases by Primary Care Physicians & Their Support Staff CME Conference, Omaha, Nebraska, 2013
  • Poster Presentation -
    “Interlukin-6 as a Therapeutic Target in Pseudomyxoma Peritonei:  Effects of an Anti-Interleukin-6 Monoclonal Antibody on Cell Proliferation in a Surrogate Cell Line,” American Society of Clinical Oncology GI Symposium, San Francisco, California, 2013
  • “Pseudomyxoma Peritonei and Peritonel Carcinomatosis” with Dr. Brian Loggie, Creighton Cancer Center, 2013
  • Poster Presentation -
    “Successful Partnership to Advocate for a Paid Parental Leave Policy at a Catholic Jesuit University,” Group on Women in Medicine and Science Poster Session, Annual Meeting of the Association of American Medical Colleges, San Francisco, California, 2012
  • “Prognostic Markers in Breast Cancer Treatment”, 2012
  • “Integrated Pathology Education”, 2012
  •  “Integrated Pathology Education,” Annual Meeting of the Undergraduate Medical Educators Section of Association of Pathology Chairs, Monterey, California, 2012
  • “Lynch Syndrome and MSI testing,” Pathology Symposium, Lady Hardinge Medical College, Delhi, India, 2012
  • National Platform Presentation -
    “Role of MUC4 in Lung Cancer.” Combined Annual Meeting of Central Society for Clinical Research (CSCR) and the Midwestern Section of the American Federation for Medical Research Combined Annual Meeting. Chicago, Illinois
     , 2012
  • International Platform Presentation -
    “Imatinib mesylate facilitating surgical removal of metastatic fibrosarcomatous-dermatofibrosarcoma protuberans (FS-DFSP): A case report highlighting the pathologic and molecular features of FS-DFSP both pre- and post-treatment with Imatinib.” Annual Meeting of the United States and Canadian Academy of Pathology, Vancouver, Canada
     , 2012
  • “Predictive and Prognostic Factors In Breast Cancer - Morphology Or Molecular Profile?”   Leicester General Hospital, Leicester, England, 2012
  • National Platform Presentation -
    “Proposed new classification for Pseudomyxoma Peritonei.” Annual meeting of the Academic Surgical Congress, Las Vegas, Nevada, 2012
  • Poster Presentation -
    “Microenvironment and Cytokines in Pseudomyxoma Peritonei,” American Society of Clinical Oncology GI Symposium, San Francisco, CA, 2012
  • “Digital Photography in Pathology,” The Group on Research in Pathology Education, Annual Meeting, Tampa, Florida, 2012

Awards and Honors

  • Member, National Registry of Madison's "Who's Who", 2007